Page 48 - Registration Document News Today

ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma Cambridge, MA...

... | June 12, 2023

Press ReleaseVELIZY-VILLACOUBLAY — June 9, 2023 Dassault Systèmes’ Capital Markets Day: Doubling non-IFRS EPS by 2028 to €2.20 - €2.40, Announcing Pascal Daloz as Chief... | June 9, 2023

PARIS--(BUSINESS WIRE)--Regulatory News:The Combined General Meeting of shareholders of Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering from rare renal diseases, met on June 8, 2...

SOITEC CAPITAL MARKETS DAYEXPANDING OUR SUSTAINABLE VALUE-CREATION MODEL Soitec confirms its FY'26 strategic roadmap: revenue expected around US$2.1bn and EBITDA1 margin2 around 40%3, leading to a

Tech Foundations Highlights Plan to Refocus, Recover and Rebound, and Upgrades Mid-Term Ambitions Redefining portfolio around core activities and pivoting in industry-leading offerings with focus on... | June 7, 2023

SOITEC REPORTS FULL-YEAR RESULTS OF FISCAL YEAR 2023 Revenue reached €1.1bn, up 26% on a reported basis and up 19% at constant exchange rates and perimeterEBITDA1 margin2 reached 36% of... | June 7, 2023

Regulatory News: ORPEA filed, today, its 2022 Universal Registration Document (document d'enregistrement universel) with the French Autorité des Marchés Financiers ("AMF"). The 2022 Universal Registration

Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); June 7, 2023 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage...

Lille ; Cambridge ; Zurich ; June 7, 2023 - GENFIT , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases, today announced that it... | June 9, 2023